Ameriprise
CANO

Ameriprise’s Cano Health, Inc. CANO Stock Holding History

Ameriprise’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,183
Closed -$581K – 3997
2023
Q2 		$581K Sell
4,183
-939
-18% -$120K ﹤0.01% 3381
2023
Q1 		$466K Buy
5,122
+1,448
+39% +$197K ﹤0.01% 3458
2022
Q4 		$503K Buy
3,674
+61
+2% +$20.6K ﹤0.01% 3408
2022
Q3 		$3.13M Sell
3,613
-108
-3% -$67.7K ﹤0.01% 2550
2022
Q2 		$1.63M Buy
3,721
+1,763
+90% +$919K ﹤0.01% 2898
2022
Q1 		$1.24M Buy
1,958
+1,044
+114% +$658K ﹤0.01% 3116
2021
Q4 		$814K Buy
914
+678
+287% +$712K ﹤0.01% 3348
2021
Q3 		$299K Buy
+236
New +$286K ﹤0.01% 3575

Other funds holding CANO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Ameriprise's CANO Position: Q3 2023 in Review

Ameriprise sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 4,183 shares — an estimated $581K sold.

Ameriprise first reported a position in CANO in Q3 2021 and held it in 8 quarters. The position peaked at $3.13M in Q3 2022. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Ameriprise reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Ameriprise sold 4,183 Cano Health, Inc. shares in Q3 2023, an estimated $581K.
  • Ameriprise first reported a position in Cano Health, Inc. in Q3 2021 and held it in 8 quarters.
  • Ameriprise's Cano Health, Inc. position peaked at $3.13M in Q3 2022.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Ameriprise's 13F filing for Q3 2023, filed 14 Nov 2023.